Jazz Pharmaceuticals gets Cramer backing in CNBC stock call segment
Jim Cramer is weighing a fresh set of rapid-fire stock calls as investors look for signals on speculative and rate-sensitive names. In the latest lightning round, he backs Jazz Pharmaceuticals ...